drugset / Trial / NCT00006367

Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Myelofibrosis

NCT00006367

Treatment

Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining chemotherapy with peripheral stem cell transplantation may allow the doctor to give higher doses of chemotherapy drugs and kill more cancer cells. PURPOSE: Phase II trial to study the effectiveness of chemotherapy followed by peripheral stem cell transplantation in treating patients who have myelofibrosis.

Timeline

Start
2000-05
Primary completion
Completion
2004-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Busulfan Small molecule 16 mg/kg Oral
Subject Cytarabine Small molecule Intravenous
Subject Idarubicin Small molecule Intravenous
Background filgrastim Protein / enzyme biologic Subcutaneous